Omada Health, Inc. (NASDAQ:OMDA) Receives Consensus Rating of “Moderate Buy” from Analysts

Omada Health, Inc. (NASDAQ:OMDA) has received an average recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating on the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $26.50.

A number of brokerages have weighed in on OMDA. Citizens Jmp boosted their price target on Omada Health from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research report on Friday, August 14th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. BTIG Research upped their price objective on shares of Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a report on Monday, August 10th. BMO Capital Markets reissued an “outperform” rating and issued a $24.00 price objective on shares of Omada Health in a research report on Friday, August 7th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 target price on shares of Omada Health in a report on Monday, June 22nd.

Insider Transactions at Omada Health

In other Omada Health news, CFO Steven Cook sold 33,000 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the completion of the transaction, the chief financial officer directly owned 133,359 shares in the company, valued at $2,652,510.51. The trade was a 19.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sean Duffy sold 25,886 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total transaction of $587,094.48. Following the sale, the chief executive officer directly owned 411,861 shares in the company, valued at $9,341,007.48. This trade represents a 5.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 277,406 shares of company stock valued at $5,907,726. 6.38% of the stock is owned by insiders.

Institutional Trading of Omada Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Corient Private Wealth LP increased its position in Omada Health by 252.5% in the second quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock worth $3,185,000 after buying an additional 103,955 shares during the last quarter. California State Teachers Retirement System increased its holdings in Omada Health by 465.1% in the 2nd quarter. California State Teachers Retirement System now owns 10,229 shares of the company’s stock worth $225,000 after acquiring an additional 8,419 shares during the last quarter. Round Rock Advisors LLC purchased a new stake in Omada Health during the second quarter valued at about $745,000. Susquehanna Fundamental Investments LLC bought a new position in Omada Health during the second quarter worth about $503,000. Finally, Hsbc Holdings PLC bought a new position in Omada Health during the second quarter worth about $435,000.

Omada Health Trading Up 2.2%

Shares of OMDA opened at $22.77 on Monday. The stock has a market cap of $1.39 billion, a P/E ratio of 455.40 and a beta of 1.86. Omada Health has a 1 year low of $10.28 and a 1 year high of $26.92. The stock’s 50-day moving average price is $22.70 and its two-hundred day moving average price is $17.58.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. As a group, equities analysts forecast that Omada Health will post 0.09 EPS for the current year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.